Učitavanje...
Single tranexamic acid dose to reduce perioperative morbidity in primary total hip replacement: a randomised clinical trial
INTRODUCTION: Although prophylactic tranexamic acid (TXA) is a safe, low-cost option to reduce bleeding in patients undergoing total hip replacement (THR), its optimal dose and duration is unknown. We compared the safety and effectiveness of TXA given as either a single injection or continuous infus...
Spremljeno u:
| Izdano u: | Hip Int |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SAGE Publications
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6159839/ https://ncbi.nlm.nih.gov/pubmed/24062227 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5301/hipint.5000090 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|